Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators


Por: Muratov, S, Canelo-Aybar, C, Tarride, JE, Alonso-Coello, P, Dimitrova, N, Borisch, B, Castells, X, Duffy, SW, Fitzpatrick, P, Follmann, M, Giordano, L, Hofvind, S, Lebeau, A, Quinn, C, Torresin, A, Vialli, C, Siesling, S, Ponti, A, Rossi, PG, Schunemann, H, Nystrom, L, Broeders, M, ECIBC Contributor Grp

Publicada: 24 ago 2020
Resumen:
BackgroundIn the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. This paper documents the methodology used for the indicator selection.MethodsThe indicators were identified through a multi-stage process. First, a scoping review was conducted to identify existing performance indicators. Second, building on existing frameworks for making well-informed health care choices, a specific conceptual framework was developed to guide the indicator selection. Third, two group exercises including a rating and ranking survey were conducted for indicator selection using pre-determined criteria, such as: relevance, measurability, accurateness, ethics and understandability. The selected indicators were mapped onto a BC screening pathway developed by the M&E subgroup to illustrate the steps of BC screening common to all EU countries.ResultsA total of 96 indicators were identified from an initial list of 1325 indicators. After removing redundant and irrelevant indicators and adding those missing, 39 candidate indicators underwent the rating and ranking exercise. Based on the results, the M&E subgroup selected 13 indicators: screening coverage, participation rate, recall rate, breast cancer detection rate, invasive breast cancer detection rate, cancers >20mm, cancers <= 10mm, lymph node status, interval cancer rate, episode sensitivity, time interval between screening and first treatment, benign open surgical biopsy rate, and mastectomy rate.ConclusionThis systematic approach led to the identification of 13 BCSP candidate performance indicators to be further evaluated for their association with BC mortality.

Filiaciones:
Muratov, S:
 McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

Canelo-Aybar, C:
 CIBERESP, Inst Invest Biomed St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain

Tarride, JE:
 McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

Alonso-Coello, P:
 CIBERESP, Inst Invest Biomed St Pau IIB St Pau, Iberoamer Cochrane Ctr, Barcelona, Spain

Dimitrova, N:
 European Commiss, Joint Res Ctr, Via E Fermi 2749 TP 127, I-21027 Ispra, VA, Italy

Borisch, B:
 Univ Geneva, Inst Global Hlth, Geneva, Switzerland

Castells, X:
 IMIM Hosp del Mar, Med Res Inst, Barcelona, Spain

Duffy, SW:
 Queen Mary Univ London, London, England

Fitzpatrick, P:
 Natl Screening Serv, Dublin, Ireland

 UCD, Sch Publ Hlth Physiotherapy & Sports Sci, Dublin, Ireland

Follmann, M:
 German Canc Soc, Berlin, Germany

Giordano, L:
 CPO Piedmont AOU Citta Salute & Sci, Turin, Italy

Hofvind, S:
 Canc Registry Norway, Oslo, Norway

Lebeau, A:
 Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany

 Private Grp Practice Pathol, Hamburg, Germany

Quinn, C:
 St Vincents Univ Hosp, Dublin, Ireland

Torresin, A:
 ASST Grande Osped Metropolitano, Milan, Italy

Vialli, C:
 European Commiss, Joint Res Ctr, Via E Fermi 2749 TP 127, I-21027 Ispra, VA, Italy

Siesling, S:
 Netherlands Comprehens Canc Org IKNL, Utrecht, Netherlands

 Univ Twente, Enschede, Netherlands

Ponti, A:
 CPO Piedmont AOU Citta Salute & Sci, Turin, Italy

Rossi, PG:
 AUSL Reggio Emilia, IRCCS, Reggio Emilia, Italy

Schunemann, H:
 McMaster Univ, Fac Hlth Sci, Dept Hlth Res Methods Evidence & Impact, Hamilton, ON, Canada

Nystrom, L:
 Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden

Broeders, M:
 Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Med Ctr, Nijmegen, Netherlands
ISSN: 14712407
Editorial
BMC, CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 20 Número: 1
Páginas:
WOS Id: 000571537900005
ID de PubMed: 32831048
imagen Gold, Green Published

MÉTRICAS